Fraile, A. (A.)

Filtering

19971

Settings

Author search.filters.isAuthorOfPublication.802cca22-d87a-45a9-a20a-af3b9861beb5

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations
    (Wiley-Blackwell, 1997) Cigudosa, J.C. (Juan Cruz); Carrasco, J. (J.L.); Sole, F. (Francesc); Ferreira, C. (C.); Cuesta, B. (Braulia); Ardanaz, M.T. (M.T.); Calasanz-Abinzano, M.J. (Maria Jose); Odero, M.D. (Maria Dolores); Gullon, A. (Arturo); Fraile, A. (A.)
    Cytogenetic analysis of unstimulated short-term bone marrow cell cultures was performed on 280 patients with multiple myeloma and related disorders. In 65% of the cases, an additional short term B-cell stimulated culture was also examined. Chromosomally abnormal clones were found in 31% of the patients, 15% in Waldenström macroglobulinemia. 25% in monoclonal gammopathies, 33% in multiple myeloma, and 50% in plasma cell leukemia. Three primary chromosomal breakpoints were recurrently involved: 14q32, 16q22, and 22q11. Structural rearrangements of chromosome 1 were the most frequent (26% of the abnormal cases), but always as a secondary change. Rearrangements of band 14q32 were found in 22% of the abnormal cases. Among the multiple myeloma patients who showed an abnormal karyotype, 33 (46%) were hyperdiploid, most frequently, with 52-56 chromosomes, 29 patients (40%) were pseudodiploid, and the remaining 12 cases (14%) were hypodiploid. A highly significant relation was observed between the presence of an abnormal karyotype and the following clinical parameters: stage III (P = 0.0001), bone marrow plasma cell infiltration greater than 30% (P = 0.0001), presence of bone lesions (P = 0.0009), and beta 2-microglobulin levels greater than 4 mg/L (P = 0.0001).